Levemir (Insulin Detemir)



Indications and Reactions:

Role Indications Reactions
Primary
Insulin-requiring Type Ii Diabetes Mellitus 66.7%
Type 1 Diabetes Mellitus 33.3%
Blood Glucose Decreased 33.3%
Myalgia 33.3%
Weight Decreased 33.3%
Secondary
Product Used For Unknown Indication 41.8%
Diabetes Mellitus 10.9%
Angina Pectoris 7.3%
Cardiac Failure 7.3%
Type 1 Diabetes Mellitus 7.3%
Type 2 Diabetes Mellitus 5.5%
Diabetes Mellitus Insulin-dependent 3.6%
Gastrooesophageal Reflux Disease 3.6%
Hypokalaemia 3.6%
Lung Neoplasm Malignant 3.6%
Metastases To Central Nervous System 3.6%
Plasma Cell Myeloma 1.8%
Vomiting 18.2%
Blood Glucose Increased 9.1%
Haematoma 9.1%
Infarction 9.1%
Injection Site Haematoma 9.1%
Injection Site Urticaria 9.1%
Malaise 9.1%
Pain In Extremity 9.1%
Rash 9.1%
Urticaria 9.1%
Concomitant
Type 2 Diabetes Mellitus 43.3%
Insulin-requiring Type 2 Diabetes Mellitus 14.6%
Chronic Myeloid Leukaemia 4.7%
Insulin-requiring Type Ii Diabetes Mellitus 4.7%
Product Used For Unknown Indication 4.7%
Plasma Cell Myeloma 4.1%
Diabetes Mellitus 2.9%
Neoplasm Malignant 2.9%
Prostate Cancer 2.3%
Drug Use For Unknown Indication 1.8%
Hypertension 1.8%
Immunodeficiency Common Variable 1.8%
Lupus Nephritis 1.8%
Myelodysplastic Syndrome 1.8%
Drug Use For Unknown Indication 1.2%
Breast Cancer Metastatic 1.2%
Diabetic Retinal Oedema 1.2%
Glycosylated Haemoglobin Increased 1.2%
Hepatitis C 1.2%
Lung Transplant 1.2%
Weight Decreased 29.8%
Vomiting 14.0%
Blood Glucose Increased 12.3%
Weight Increased 7.0%
Pancreatitis 5.3%
Bladder Cancer 3.5%
Malaise 2.6%
Nausea 2.6%
Psychotic Disorder 2.6%
Syncope 2.6%
Blood Glucose Fluctuation 1.8%
Drug Effect Decreased 1.8%
Dysgeusia 1.8%
Feeling Jittery 1.8%
Hypoglycaemia 1.8%
Nasopharyngitis 1.8%
Off Label Use 1.8%
Panniculitis 1.8%
Pruritus 1.8%
Pulmonary Oedema 1.8%